Blog

Eleonora Teplinsky: One of the main themes at this year’s SABCS was SERDs

Eleonora Teplinsky/valleyhealth.com

Dec 15, 2024, 21:15

Eleonora Teplinsky: One of the main themes at this year’s SABCS was SERDs

“One of the main themes at this year’s San Antonio Breast Cancer Symposium was SERDs (selective estrogen receptor degraders) in both early-stage and metastatic breast cancer.

In this video, I talk about what they are, how they work and how we are using them – and ongoing clinical trials.”

Co-Founder and Business Development Officer of Surviving Breast Cancer, shared this post, adding:

“Well said Dr. Teplinsky…SERDs have been shown to be quite important in the treatment of estrogen receptor-positive (ER+) breast cancer, particularly for patients who have developed resistance to other forms of endocrine therapy.”

Proceed to the video attached to the post.

More posts featuring Eleonora Teplinsky.

Eleonora Teplinsky is a medical oncologist specializing in breast and gynecologic oncology. She is the head of breast and gynecological medical oncology at Valley-Mount Sinai Comprehensive Cancer Care in Paramus, New Jersey, and a clinical assistant professor of medicine at the Icahn School of Medicine at Mount Sinai in New York. Her clinical and research interests focus on young women with breast cancer, survivorship, exercise oncology, and the use of social media in oncology.

She is passionate about oncology education and advocacy on social media and is the host of the INTERLUDE Podcast, where she shares the stories and experiences of those who have been affected by cancer. Dr. Teplinsky is the co-lead of the The Collaboration for Outcomes using Social Media in Oncology (COSMO) – a social media lab working to provide a venue for social media research in oncology.